Document is current

Any future updates will be listed below

Anifrolumab: the new frontier in the treatment of genetic interferonopathies

Crossref DOI link: https://doi.org/10.1136/rmdopen-2024-004780

Published Online: 2024-09-23

Published Print: 2024-09

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark